PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 102 filers reported holding PROVENTION BIO INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,016,000 | -43.2% | 96,800 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,790,000 | +29.5% | 105,689 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $1,382,000 | +4.4% | 107,689 | +14.8% | 0.00% | 0.0% |
| Q2 2020 | $1,324,000 | +108.5% | 93,802 | +35.8% | 0.00% | 0.0% |
| Q1 2020 | $635,000 | -6.5% | 69,074 | +51.6% | 0.00% | 0.0% |
| Q4 2019 | $679,000 | – | 45,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |